Canada markets closed

Aequus Pharmaceuticals Inc. (AQS.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.07000.0000 (0.00%)
At close: 03:52PM EDT
Full screen
Previous Close0.0700
Bid0.0650 x 0
Ask0.0850 x 0
Day's Range0.0700 - 0.0700
52 Week Range0.0650 - 0.1600
Avg. Volume11,979
Market Cap9.284M
Beta (5Y Monthly)0.63
PE Ratio (TTM)N/A
EPS (TTM)-0.0130
Earnings DateJul 04, 2022 - Jul 05, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.52
  • GlobeNewswire

    Aequus Provides General Update and Reports Record 2021 Financial Results

    Also reports Financial Results for the 3 months ended March 31, 2022 VANCOUVER, British Columbia, July 01, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a sales force that currently markets third party or exclusively licensed products for which the Company receives revenues from direct product sales and profit share arrangements, today reported financial results for the year ended December 31,

  • GlobeNewswire

    Aequus Provides Update on Delay in Filing Annual Financial Statements

    VANCOUVER, British Columbia, June 13, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”) announces that further to its news release on May 6, 2022 and May 26, 2022, the filing of its audited annual financial statements for the fiscal year ended December 31, 2021 and the related management’s discussion and analysis (collectively, the “Annual Disclosure”) as well at the financial statements for the three months ended March 31, 2022 and the r

  • CNW Group

    IIROC Trading Halt - AQS

    The following issues have been halted by IIROC: